Binder profile
ZINC3581269
Virtual-screening candidate from ZINC.
Bound to: PA0206 — spermidine/putrescine ABC transporter ATP-binding protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3581269- UniProt (similar protein)
Q9KIF7- Tanimoto
- 1.000
- Target protein
- PA0206
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 329.2
- LogP ≤ 5 -0.82
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 154.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2CO[P@](=O)(O)O[C@H]2[C@@H]1ONc1ncnc2c1ncn2[C@@H]1O[C@@H]2CO[P@](=O)(O)O[C@H]2[C@@H]1O
InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6+,7-,10-/m1/s1InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6+,7-,10-/m1/s1
IVOMOUWHDPKRLL-GAWUUDPSSA-NIVOMOUWHDPKRLL-GAWUUDPSSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 2BA
- Homolog
- Q9KIF7
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3581269 →
- ZINC ZINC20 ZINC3581269 →
- UniProt UniProt Q9KIF7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3581269”) →
Other binders for this protein
Quick navigation to other ligands bound to PA0206.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).